Varta
← Back to stories

From The Hindu

Center-Left Owned by Kasturi & Sons Ltd.

CSIR-CCMB develops India-specific tool to predict Sickle Cell severity

CSIR-CCMB develops India-specific tool to predict Sickle Cell severity

RSS excerpt

The new tool could improve treatment decisions and disease management as existing international scoring systems do not accurately reflect the clinical profile of Indian patients with SCA

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 1 (100%)
Center 0 (0%)
Center-Right / Right 0 (0%)

Read more news

See all latest stories →